Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Jounce Therapeutics Inc (NQ: JNCE )

12.55 USD +0.55 (+4.58%)
Official Closing Price Updated: 7:30 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 807,400
Open 11.86
Bid (Size) 12.40 (1)
Ask (Size) 12.93 (1)
Prev. Close 12.00
Today's Range 11.57 - 12.74
52wk Range 2.850 - 12.74
Shares Outstanding 32,483,442
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Jounce Therapeutics Announces Initiation of Phase 1 INNATE Study of JTX-8064 (LILRB2/ILT4 Inhibitor) Monotherapy and PD-1 Inhibitor Combination Therapy in Patients with Advanced Solid Tumors
From GlobeNewswire News Releases
Jounce Therapeutics to Present at Upcoming Investor Conferences in January
From GlobeNewswire News Releases

Performance

YTD
+85.38%
+85.38%
1 Month
+90.15%
+90.15%
3 Month
+32.24%
+32.24%
6 Month
+158.23%
+158.23%
1 Year
+92.19%
+92.19%

More News

Read More
Jounce Therapeutics Added to NASDAQ Biotechnology Index
From GlobeNewswire News Releases
Jounce Therapeutics to Participate in a Fireside Chat at the Piper Sandler 32nd Annual Virtual Healthcare Conference
From GlobeNewswire News Releases
Jounce Therapeutics Receives Study May Proceed Letter from US FDA to Initiate Phase 1 Clinical Trial of JTX-8064 Targeting the LILRB2/ILT4 Mechanism
From GlobeNewswire News Releases
Jounce Therapeutics Presents Preclinical Data from JTX-8064 Program at the Society for Immunotherapy of Cancer’s (SITC) 35th Annual Meeting
From GlobeNewswire News Releases
Jounce Therapeutics to Participate in a Virtual Fireside Chat at Cowen 2020 IO Next Summit
From GlobeNewswire News Releases
12 Health Care Stocks Moving In Thursday's After-Market Session
Tags ADMP Movers BWAY
From Benzinga
Jounce Therapeutics Reports Third Quarter 2020 Financial Results
From GlobeNewswire News Releases
JNCE Crosses Above Average Analyst Target
Tags ETFs
From ETF Channel
Implied FDM Analyst Target Price: $57
Tags ETFs
From ETF Channel
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]